ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced pancreatic cancer: phase 3 trial launches
Disease control Not yet recruitingThis phase 3 study tests whether adding the experimental drug MRG004A to standard supportive care helps people with advanced pancreatic cancer live longer. About 231 adults whose cancer has not responded to prior treatments will receive either MRG004A or a placebo, along with bes…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 13:54 UTC
-
New hope for pancreatic cancer: drug combo aims to shrink tumors
Disease control Not yet recruitingThis study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. About 40 adu…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Nelum Corp • Aim: Disease control
Last updated May 13, 2026 16:02 UTC